Neuronetics appoints Joseph H. Capper to board, adopts amended bylaws

appointed Joseph H. Capper as a director and member of the Board’s Audit Committee effective January 1, 2023.

On December 27, 2022, the Board voted to adopt the Fourth Amended and Restated Bylaws (the “A&R Bylaws”), which became effective immediately upon adoption. The A&R Bylaws amend and restate the Company’s previously existing bylaws in their entirety to, among other things, (i) update provisions as a result of universal proxy rules adopted by the SEC with respect to the nomination of directors for election, including a requirement for a stockholder submitting a nomination notice to make a representation as to whether such stockholder intends to solicit proxies in support of director nominees other than the Company’s nominees in accordance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and to provide reasonable evidence that certain requirements of such rule have been satisfied; and (ii) make certain other administrative, modernizing, clarifying and conforming changes.